Evidence mapPaperPMID 41373745Full record

ArticleInternational journal of molecular sciences2025

Human miRNAs in Cancer: Statistical Trends and Cross Kingdom Approach.

Maksym Zoziuk, Vittorio Colizzi, Maurizio Mattei, Pavlo Krysenko, Roberta Bernandini, Fabio Massimo Zanzotto, Stefano Marini, Dmitri Koroliouk

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maksym ZoziukInterdepartmental Center for Comparative Medicine, Alternative Techniques, and Aquaculture, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.ORCID 0000-0001-9116-7217
Vittorio ColizziFaculty of Medicine, University of Rome Tor Vergata, Via della Ricerca Scientica 1, 00173 Rome, Italy.ORCID 0000-0003-0007-8580
Maurizio MatteiInterdepartmental Center for Comparative Medicine, Alternative Techniques, and Aquaculture, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.ORCID 0000-0002-0814-8873
Pavlo KrysenkoInstitute of Telecommunications and Global Information Space, National Academy of Sciences of Ukraine, Chokolivskiy bulv. 13, 03186 Kyiv, Ukraine.
Roberta BernandiniDepartment of Clinical Sciences and Translational Medicine, Faculty of Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Roma, Italy.ORCID 0000-0002-1675-0645
Fabio Massimo ZanzottoDepartment of Business Engineering "Mario Lucertini", University of Rome Tor Vergata, Via del Politecnico, 1, 00133 Rome, Italy.ORCID 0000-0002-7301-3596
Stefano MariniDepartment of Clinical Sciences and Translational Medicine, Faculty of Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Roma, Italy.ORCID 0000-0003-1299-6696
Dmitri KorolioukInterdepartmental Center for Comparative Medicine, Alternative Techniques, and Aquaculture, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.ORCID 0000-0003-2765-3450

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally and are frequently dysregulated in cancer. While most studies focus on individual miRNAs, global patterns and their potential cross-kingdom similarities remain underexplored. This study aims to identify statistically stable human miRNAs in cancer, their key target genes, and analyze sequence complementarity with plant miRNAs to highlight patterns for future research. Experimentally validated human miRNA-gene interactions from miRTarBase were integrated with TCGA expression data across multiple cancers. Using a nonlinear threshold (critical threshold III), 115 underexpressed and 93 overexpressed miRNAs were identified as regulators of 200 genes with the strongest dysregulation. Further, 10,898 plant miRNAs from 127 species were computationally compared to these human miRNAs, and average complementarity scores were calculated to identify plant miRNAs most similar to under- or overexpressed human miRNAs. Statistical parameters such as membership ratios and experiment counts quantified miRNA expression stability. Subsets of human miRNAs exhibited consistent over- or underexpression across cancers, with concordant target gene expression patterns. Several plant miRNAs showed higher complementarity to underexpressed human miRNAs, suggesting reproducible cross-kingdom sequence similarity patterns. Differences in complementarity were modest but systematic, providing a computational framework for prioritizing candidate miRNAs for further study. This work establishes a computational approach integrating human miRNA-gene interactions, cancer expression data, and plant miRNA sequences. It identifies statistically stable miRNAs, key target genes, and cross-kingdom sequence similarities without implying functional or therapeutic activity. The framework can guide future experimental studies in miRNA regulation, comparative genomics, and molecular evolution.

Indexed as

MicroRNAsNeoplasmsComputational BiologyGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansMicroRNAscancer bioinformaticscross-kingdom comparisonmicroRNA (miRNA)plant miRNAsequence similarity

Identifiers

PMID41373745
PMCPMC12692678

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.